Therapeutic Areas

Advancing Oncology Research

We have a long and proven track record in the development of small molecules for oncology.  We help our partners advance cancer programs from discovery through target identification, lead generation, lead optimization, IND filing and then NDA filing.

Axcelead focuses on biology and following the data.

We harness our wealth of expertise in target identification/validations, in vitro cell based assays, in vivo studies and translational research to achieve compounds with optimal profiles to perform well in the preclinical, clinical and real-world settings.

And given our success in this area, we are leveraging these learnings and expanding into immuno-oncology to create drugs that affect the cancer tumor microenvironment and host immunity.

We are ready to partner with you.